3 ms·
I really find this suboptimal. Why not use the mRNA to create antigens outside of the human body and then use a more traditional delivery? I like the Novavax ap
by nikolay 6y ago
I really find this suboptimal. Why not use the mRNA to create antigens outside of the human body and then use a more traditional delivery? I like the Novavax approach using a saponin adjuvant. I'm sure there are other similar approaches.